Literature DB >> 6312686

Rapid induction of osteopetrosis by subgroup E recombinant viruses.

J H Morgan, R E Smith.   

Abstract

Avian osteopetrosis is a proliferative bone disorder initiated at high frequency by MAV-2(O), a subgroup B avian myeloblastosis-associated virus. To examine the role of the MAV-2(O) genome in osteopetrosis induction, a series of recombinant viruses between MAV-2(O) and RAV-O was constructed. Recombinant viruses were selected for rapid growth and subgroup E envelopes. The T1 oligonucleotide fingerprint patterns of viruses selected in this manner demonstrated that they were recombinants and were clonally pure because they had oligonucleotides from each parent, and each oligonucleotide was present in single molar yield. When injected into 10-day-old chicken embryos, approximately 50% of the recombinant viruses induced osteopetrosis within 3 weeks after hatch. Therefore, subgroup E envelope did not inhibit osteopetrosis induction. The osteopetrosis that was induced varied from slight to severe, but none of the recombinant viruses induced osteopetrosis as severe as the MAV-2(O) parent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312686     DOI: 10.1016/0042-6822(83)90189-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Transformation of Brown Leghorn chicken embryo fibroblasts by avian myeloblastosis virus proviral DNA.

Authors:  J Soret; C Kryceve-Martinerie; J Crochet; B Perbal
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

2.  Induction of nephroblastoma by myeloblastosis-associated virus type 1: state of proviral DNAs in tumor cells.

Authors:  J Soret; G Dambrine; B Perbal
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  MAV-2-O replicates at a reduced rate in cells from the osteopetrosis resistant G-B1 chicken.

Authors:  J Böni; M Böni-Schnetzler; R M Frank; R M Franklin
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.